While the pharmaceutical industry is relatively concentrated already, consolidation will continue in the future as companies struggle with high R&D costs and uncertain pipeline success rates. Drawing on its extensive experience guiding clients through uncertainty, and mergers and acquisitions, CAP partners with clients to ensure that executive compensation supports a successful close and integration process. CAP helps its pharmaceutical clients improve their ability to attract, retain, and motivate key executive talent in order to achieve their growth strategies. Learn more about CAP’s expertise in the pharmaceutical industry here or contact us for additional information.
Upcoming Events See All
Mar 04, 2025
Navigating the 2025 Proxy Season
Compensation Advisory Partners, 1180 Ave of the Americas 22nd Fl, New York, NY 10036
Join Shaun Bisman and Chris Callegari from Compensation Advisory Partners for a compelling discussion on the critical issues shaping the 2025 proxy season. This…